Allianz Asset Management »

Vera Therapeutics shares owned by Allianz Asset Management

Quarter-by-quarter ownership of Vera Therapeutics (VERA) shares owned by Allianz Asset Management from 13F filings

Historical chart of Allianz Asset Management investment in Vera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Vera Therapeutics held by Allianz Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vera Therapeutics by Allianz Asset Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $554k 15k 36.18

More positions owned by Allianz Asset Management

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
UnitedHealth (UNH)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. Call Option (JPM)
Adobe Systems Incorporated (ADBE)
Vici Pptys (VICI)
Applied Materials (AMAT)
Ishares Tr Msci Emg Mkt Etf (EEM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Eli Lilly & Co. (LLY)

View all positions for Allianz Asset Management

Top funds holding Vera Therapeutics

T. Rowe Price Associates
BlackRock
BlackRock
Sofinnova Ventures
Vanguard Group
Commodore Capital
State Street Corporation
Holocene Advisors
Kynam Capital Management
Samlyn Capital
Paradigm Biocapital Advisors
Geode Capital Management
Woodline Partners
T. Rowe Price Investment Management
Logos Global Management

View all funds holding Vera Therapeutics